ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,516Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 2604

$561K Total Retail Price of All Prescriptions

Rank: 149 out of 2604

566 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 566 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 566 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

0% of this provider’s 10,820 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 574 557 1 4
LISINOPRIL 472 454 2 3
FUROSEMIDE 468 449 3 8
WARFARIN SODIUM 445 409 4 13
HYDROCODONE-ACETAMINOPHEN 310 286 S3 5 1
OMEPRAZOLE 262 254 6 5
TRAMADOL HCL 259 253 7 15
POLYETHYLENE GLYCOL 3350 255 221 8 42
DONEPEZIL HCL 238 236 9 28
ESCITALOPRAM OXALATE 233 223 10 73
AMLODIPINE BESYLATE 220 204 11 6
SIMVASTATIN 215 208 12 2
CITALOPRAM HBR 199 199 13 18
POTASSIUM CHLORIDE 190 186 14 16
METOPROLOL TARTRATE 175 168 15 9
GABAPENTIN 167 158 16 12
METOPROLOL SUCCINATE 161 147 17 17
FENTANYL 151 150 S2 18 48
CARVEDILOL 143 141 19 26
LANTUS 133 124 20 40
CARBIDOPA-LEVODOPA 126 126 21 97
FAMOTIDINE 122 120 22 68
MIRTAZAPINE 120 120 23 52
HYDRALAZINE HCL 118 106 24 85
ATORVASTATIN CALCIUM 112 108 25 19
ATENOLOL 107 105 26 11
SERTRALINE HCL 102 77 27 23
LOVASTATIN 100 86 28 24
NOVOLOG 99 95 29 89
CLOTRIMAZOLE-BETAMETHASONE 97 95 30 138
QUETIAPINE FUMARATE 96 95 31 66
ALENDRONATE SODIUM 96 96 31 29
NAMENDA 88 88 33 37
KLOR-CON M20 83 82 34 86
TAMSULOSIN HCL 81 80 35 30
ALLOPURINOL 79 78 36 35
CEPHALEXIN 75 70 37 74
OXYBUTYNIN CHLORIDE ER 75 72 37 110
PANTOPRAZOLE SODIUM 74 70 39 64
LEXAPRO 71 65 40 253
CLOPIDOGREL 71 71 40 39
METFORMIN HCL 70 65 42 7
ISOSORBIDE MONONITRATE ER 70 69 42 38
CIPROFLOXACIN HCL 69 66 44 59
CYMBALTA 66 58 45 44
NYSTATIN 64 62 46 100
GLIPIZIDE 63 51 47 51
FENOFIBRATE 62 59 48 69
ROPINIROLE HCL 62 62 48 102
FLUTICASONE PROPIONATE 62 47 48 31
DIOVAN 60 47 51 123
PLAVIX 55 53 52 75
CEFTRIAXONE 51 47 53 188
HYDROCORTISONE 51 51 53 161
PREDNISONE 50 49 55 34
HYDROCHLOROTHIAZIDE 50 39 55 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.